•  
  •  
 

Abstract

Introduction: Cavitary lung cancer is frequently found in both adenocarcinoma and squamous cell carcinoma (SCC) and the differentiation between these two types of cancers is becoming more important as the role of molecular targeted therapy is increasingly used. Objectives: To evaluate the use of CT cavitary features to differentiate between adenocarcinoma and SCC lung cancer. Methods: A retrospective study of cavitary lung lesions seen on CT scan in patients prior to treatment for pathologically proven adenocarcinoma or SCC between January 2010 and April 2021 was conducted. The chest CT findings of the tumors with cavitation, including the cavitary wall pattern, diameter of the tumor and cavity, tumoral wall thickness, location, number, intra-tumoral bronchiectasis, associated calcification, emphysema, honeycomb appearance, satellite nodules, tree-in-bud pattern, and pleural tagging, were evaluated. Results: A total of 54 patients were included in the study (74&percent; adenocarcinoma and 26&percent; SCC). The mean tumoral diameter (mean Dt), mean cavitary diameter (mean Dc), and Dc/Dt ratio tended to be greater in SCCs (p = 0.001, p = 0.002, and p = 0.030 respectively). Multiple cavities were significantly more encountered in SCCs (p = 0.021). Neither the pattern of the cavitary wall nor the rest of the other associated CT findings could help differentiate between SCC and adenocarcinoma. Conclusions: Some features such as mean Dt, mean Dc, Dc/Dt ratio, and prevalence of multiple cavities tended to be greater in SCCs compared to adenocarcinomas.

References

Tuddenham WJ. Glossary of terms for thoracic radiology: Recommendations of the Nomenclature Committee of the Fleischner Society. AJR Am J Roentgenol. 1984;143(3):50917.

Fraser RG, Paré JAP. Fraser and Paré’s Diagnosis of Diseases of the Chest. 4th ed. Vols 1–4. Radiology. 2000;217(1):262.

Chaudhuri MR. Primary pulmonary cavitating carcinomas. Thorax. 1973;28:354–66.

Mouroux J, Padovani B, Elkaim D, et al. Should cavitated bronchopulmonary cancers be considered a separate entity?. Ann Thorac Surg. 1996;61:530–2.

Theros EG. Varying manifestations of peripheral pulmonary neoplasms: A radiologic-pathologic correlative study. AJR Am J Roentgenol. 1977;128:893–914.

Onn A, Choe DH, Herbst RS, et al. Tumor cavitation in stage I non-small cell lung cancer: Epidermal growth factor receptor expression and prediction of poor outcome. Radiology. 2005;237:342–7.

Xue X, Wang P, Xue Q, et al. Comparative study of solitary thin-walled cavity lung cancer with computed tomography and pathological findings. Lung Cancer. 2012;78:45–50.

Siegel RL, Miller KD, Jemal Ahmedin. American Cancer Society. CA Cancer J Clin. 2016;66(1):7–30. doi:10.3322/caac. 21332.

MokTS,WuYL,ThongprasertS,etal.Gefitiniborcarboplatinpaclitaxel in pulmonary adenocarcinoma. N Engl J Med. 2009;361(10):947–57. doi: 10.1056/NEJMoa0810699.

Sequist LV, Yang JC, Yamamoto N, et al. Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations. J Clin Oncol. 2013;31(27):3327–34. doi:10.1200/JCO.2012.44.2806.

Woodring JH, Fried AM, Chuang VP. Solitary cavities of the lung: Diagnostic implications of cavity wall thickness. AJR Am J Roentgenol. 1980;135:1269–71.

Woodring JH, Fried AM. Significance of wall thickness in solitary cavities of the lung: A follow-up study. AJR Am J Roentgenol. 1983;140:473–4.

Nambu A, Miyata K, Ozawa K, et al. Air-containing space in lung adenocarcinoma: High-resolution computed tomography f indings. J Comput Assist Tomogr. 2002;26:1026–31.

Kunihiro Y, Kobayashi T, Tanaka N, Matsumoto T, Okada M, Kamiya M, et al. High-resolution CT findings of primary lung cancer with cavitation: A comparison between adenocarcinoma and squamous cell carcinoma. Clin Radiol. 2016;71(11):1126–31.

Li B, Ma D, Xian Z, Guan J, Luo K, Fan Q, et al. The value of multislice spiral CT features of cavitary walls in differentiating between peripheral lung cancer cavities and single pulmonary tuberculous thick-walled cavities. Br J Radiol.

Riquet M, Rivera C, Pricopi C, et al. Is the lymphatic drainage of lung cancer lobe-specific? A surgical appraisal. Eur J Cardiothorac Surg. 2014;47(3):543–9.

Kudo Y, Saji H, Shimada Y, et al. Do tumors located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumors in other lobes?. Eur J Cardiothorac Surg. 2012;42(3):414–9.

Lindell RM, Hartman TE, Swensen SJ, et al. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology. 2007;242(2):555–62.

Rosado-de-Christenson ML, Templeton PA, Moran CA. Bronchogenic carcinoma: Radiologic-pathologic correlation. Radiographics. 1994;14(2):429–46.

Download

Share

COinS